Diabetic Foot Files

Diabetes and Disability Series- Part 1 : Do I Qualify & How Long Will I Be Out of Work

24 min · 28 jun 2026
aflevering Diabetes and Disability Series- Part 1 : Do I Qualify & How Long Will I Be Out of Work artwork

Beschrijving

Dr. G dives into the complex reality of disability for people with diabetic foot ulcers — explaining why a diagnosis alone doesn’t determine disability, how occupation, ulcer characteristics, infection, blood flow, blood sugar, pressure, offloading, nutrition, and smoking affect healing, and why return-to-work decisions focus on function rather than timelines. This episode emphasizes empathetic communication, accurate documentation, realistic expectations, and the difference between temporary and permanent disability, offering a clear view of why healing varies and how clinicians and patients can work together toward recovery.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de Diabetic Foot Files community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

331 afleveringen

aflevering Forgotten Infection Friday — Nocardia: The Weakly Acid‑Fast Impostor artwork

Forgotten Infection Friday — Nocardia: The Weakly Acid‑Fast Impostor

A 62-year-old man with poorly controlled diabetes presented with weeks of cough, weight loss, night sweats, and cavitary lung lesions initially suspected to be tuberculosis or malignancy. Sputum TB tests were negative and symptoms progressed. Bronchoscopic lung biopsy showed branching gram‑positive filaments that were weakly acid‑fast, consistent with Nocardia species. Nocardia commonly infects immunocompromised hosts, can disseminate to the brain, and is often mistaken for TB, fungal infection, or cancer. Diagnosis relies on modified acid‑fast stain, prolonged cultures, or molecular testing. Treatment requires prolonged antibiotic therapy (commonly TMP‑SMX), sometimes IV agents for severe disease, and early recognition in diabetic or immunosuppressed patients is critical to prevent dissemination.

26 jun 202624 min